Japan Tobacco (2914) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Apr, 2026Executive summary
Achieved record-high revenue and profit in FY2025, driven by strong tobacco business performance, successful integration of Vector Group, and growth in processed food despite a challenging environment; pharmaceutical business was divested.
RRP segment accelerated, with Ploom Aura launched in 19 markets and significant share gains, especially in Japan.
Strategic focus on sustainable profit growth, resource allocation, and enhanced shareholder returns guided by the 4S Model.
Financial highlights
Adjusted operating profit at constant FX rose 24.9% year-on-year to ¥927.5 billion, mainly from organic tobacco business growth and Vector Group contribution.
Revenue reached ¥3,467.7 billion, up 13.4% year-on-year; profit attributable to owners increased 184.6% to ¥510.2 billion.
Free cash flow increased by ¥102.2 billion, aided by higher AOP and absence of prior year acquisition payments.
Dividend per share for FY2025 set at ¥234; FY2026 forecasted at ¥242, maintaining a ~75% payout ratio.
Outlook and guidance
FY2026 revenue forecast to rise 6.6% to ¥3,697.0 billion, with adjusted operating profit at constant FX expected to grow 8.9% to ¥964.0 billion.
Profit attributable to owners projected to increase 14.2% to ¥570.0 billion; free cash flow expected to rise further.
Dividend payout ratio targeted at approximately 75%.
Latest events from Japan Tobacco
- Q1 2025 delivered strong profit growth, pharma divestment, and new Ploom launch ahead.2914
Q1 20253 Feb 2026 - Strong tobacco pricing and RRP growth drove higher profit and raised full-year guidance.2914
Q2 20242 Feb 2026 - Revenue up 11% and US market share expanded via Vector, but profit faces cost and litigation risks.2914
Q3 202417 Jan 2026 - Record revenue and AOP in 2024, with high single-digit growth and RRP expansion targeted.2914
Q4 20248 Jan 2026 - Strong revenue and profit growth led to higher forecasts and dividend guidance for 2025.2914
Q2 20255 Nov 2025 - Record-high profit and revenue, higher guidance, and increased dividend after business divestiture.2914
Q3 202530 Oct 2025